Detalhe da pesquisa
1.
Genomic characterization of metastatic patterns from prospective clinical sequencing of 25,000 patients.
Cell
; 185(3): 563-575.e11, 2022 02 03.
Artigo
em Inglês
| MEDLINE | ID: mdl-35120664
2.
Nonlobular Invasive Breast Carcinomas with Biallelic Pathogenic CDH1 Somatic Alterations: A Histologic, Immunophenotypic, and Genomic Characterization.
Mod Pathol
; 37(2): 100375, 2024 Feb.
Artigo
em Inglês
| MEDLINE | ID: mdl-37925055
3.
Adjuvant enzalutamide for the treatment of early-stage androgen-receptor positive, triple-negative breast cancer: a feasibility study.
Breast Cancer Res Treat
; 195(3): 341-351, 2022 Oct.
Artigo
em Inglês
| MEDLINE | ID: mdl-35986801
4.
The clinical behavior and genomic features of the so-called adenoid cystic carcinomas of the solid variant with basaloid features.
Mod Pathol
; 35(2): 193-201, 2022 02.
Artigo
em Inglês
| MEDLINE | ID: mdl-34599282
5.
Next-generation assessment of human epidermal growth factor receptor 2 gene (ERBB2) amplification status in invasive breast carcinoma: a focus on Group 4 by use of the 2018 American Society of Clinical Oncology/College of American Pathologists HER2 testing guideline.
Histopathology
; 78(4): 498-507, 2021 Mar.
Artigo
em Inglês
| MEDLINE | ID: mdl-32841416
6.
A machine learning model that classifies breast cancer pathologic complete response on MRI post-neoadjuvant chemotherapy.
Breast Cancer Res
; 22(1): 57, 2020 05 28.
Artigo
em Inglês
| MEDLINE | ID: mdl-32466777
7.
Dermatologic adverse events related to the PI3Kα inhibitor alpelisib (BYL719) in patients with breast cancer.
Breast Cancer Res Treat
; 183(1): 227-237, 2020 Aug.
Artigo
em Inglês
| MEDLINE | ID: mdl-32613539
8.
Immunohistochemical analysis of estrogen receptor in breast cancer with ESR1 mutations detected by hybrid capture-based next-generation sequencing.
Mod Pathol
; 32(1): 81-87, 2019 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-30158597
9.
A phase 1b dose expansion study of the pan-class I PI3K inhibitor buparlisib (BKM120) plus carboplatin and paclitaxel in PTEN deficient tumors and with dose intensified carboplatin and paclitaxel.
Invest New Drugs
; 35(6): 742-750, 2017 12.
Artigo
em Inglês
| MEDLINE | ID: mdl-28281183
10.
Predictors of Response to CDK4/6i Retrial After Prior CDK4/6i Failure in ER+ Metastatic Breast Cancer.
Res Sq
; 2024 May 02.
Artigo
em Inglês
| MEDLINE | ID: mdl-38746324
11.
Methylation of the chromatin modifier KMT2D by SMYD2 contributes to therapeutic response in hormone-dependent breast cancer.
Cell Rep
; 43(5): 114174, 2024 May 02.
Artigo
em Inglês
| MEDLINE | ID: mdl-38700982
12.
APOBEC3 mutagenesis drives therapy resistance in breast cancer.
bioRxiv
; 2024 May 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-38746158
13.
Endogenous sex steroids in premenopausal women and risk of breast cancer: the ORDET cohort.
Breast Cancer Res
; 15(3): R46, 2013 Jun 18.
Artigo
em Inglês
| MEDLINE | ID: mdl-23777922
14.
Trends in childhood brain tumor incidence, 1973-2009.
J Neurooncol
; 115(2): 153-60, 2013 Nov.
Artigo
em Inglês
| MEDLINE | ID: mdl-23925828
15.
Clinical decision support for chemotherapy-induced neutropenia using a hybrid pharmacodynamic/machine learning model.
CPT Pharmacometrics Syst Pharmacol
; 12(11): 1764-1776, 2023 Nov.
Artigo
em Inglês
| MEDLINE | ID: mdl-37503916
16.
Sequential activation of E2F via Rb degradation and c-Myc drives resistance to CDK4/6 inhibitors in breast cancer.
Cell Rep
; 42(11): 113198, 2023 11 28.
Artigo
em Inglês
| MEDLINE | ID: mdl-37865915
17.
KIT genetic alterations in breast cancer.
J Clin Pathol
; 77(1): 40-45, 2023 Dec 14.
Artigo
em Inglês
| MEDLINE | ID: mdl-36323507
18.
Assessing Unique Risk Factors for COVID-19 Complications Among Cancer Patients: A Multi-ethnic Cohort Study.
J Immigr Minor Health
; 25(3): 624-633, 2023 Jun.
Artigo
em Inglês
| MEDLINE | ID: mdl-36344859
19.
Genomic analysis and clinical correlations of non-small cell lung cancer brain metastasis.
Nat Commun
; 14(1): 4980, 2023 08 17.
Artigo
em Inglês
| MEDLINE | ID: mdl-37591896
20.
ctDNA-based detection of molecular residual disease in stage I-III non-small cell lung cancer patients treated with definitive radiotherapy.
Front Oncol
; 13: 1253629, 2023.
Artigo
em Inglês
| MEDLINE | ID: mdl-37795442